Showing 2071-2080 of 2727 results for "".
- Candela Launches Glacē™ System at IMCAS Paris, Expands Portfolio with Matrix™ and Vbeam® Prohttps://modernaesthetics.com/news/candela-launches-glace-system-at-imcas-paris-expands-portfolio-with-matrix-and-vbeam-pro/2485539/Candela debuted its latest innovation, the Glacē™ System, during the 2026 IMCAS World Congress in Paris, marking the European launch of a platform designed to elevate facial skin treatments across aesthetic and medical settings. The system, which offers both standalone and adjunctive skin purific
- Octane Aesthetics Tech Forum: Clinical Strategies for Managing Rapid Weight Loss in Aestheticshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-clinical-strategies-for-managing-rapid-weight-loss-in-aesthetics/2485537/The widespread use of GLP-1 receptor agonists (GLP-1 RAs) is ushering in a new era of aesthetic medicine that demands a more nuanced approach to skin aging, hormonal health, and treatment planning. That was the consensus from a panel of aesthetic surgeons and regenerative medicine experts
- Octane Aesthetics Tech Forum: 3 Big Trends from GuidePoint Qsight’s 2025 Market Analysishttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-3-big-trends-from-guidepoint-qsights-2025-market-analysis/2485514/At the 2026 Octane Aesthetic Tech Forum, Erik Haines, Managing Director of Guidepoint Qsight, presented a data-rich snapshot of the state of the medical aesthetics industry. Drawing from over $17 billion in transactional data across 45,000 aesthetic practices and millions of patient records, Hain
- Tranexamic Acid in Tumescent Solution Reduces Bruising and Pain After Arm Liposuctionhttps://modernaesthetics.com/news/tranexamic-acid-in-tumescent-solution-reduces-bruising-and-pain-after-arm-liposuction/2485477/New research indicates tranexamic acid (TXA) reduced early postoperative pain and ecchymosis when added to tumescent solution during arm liposuction. The researchers, publishing in Plastic and Reconstructive Surgery, conducted a double-blind, randomized contralateral study that in
- New Study Supports Combined Approach for Facial Rejuvenationhttps://modernaesthetics.com/news/new-study-supports-combined-approach-for-facial-rejuvenation/2485450/New research in the Journal of Cosmetic Dermatology supported the use of combined radiofrequency microneedling (RFMN) and 1927 nm thulium (Tm) laser treatment versus RFMN monotherapy for lower face and neck rejuvenation in photoaged skin.
- Octane Aesthetics Tech Forum: GLP-1 Receptor Agonists Are Reshaping Consumer Behavior and Aesthetic Business Modelshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-glp-1-receptor-agonists-are-reshaping-consumer-behavior-and-aesthetic-business-models/2485431/The rise of GLP-1 receptor agonist (GLP-1RA) medications is doing more than transforming bodies; it is reshaping the very business of aesthetics. At the 2026 Octane Aesthetics Tech Forum, panelists described how GLP-1RAs are influencing patient behavior, redefining value propositions, and catalyz
- skinbetter science® Marks 10 Years of AlphaRet® Technology in Retinoid-AHA Skincarehttps://modernaesthetics.com/news/skinbetter-science-marks-10-years-of-alpharet-technology-in-retinoid-aha-skincare/2485358/skinbetter science® is marking the 10-year anniversary of its proprietary AlphaRet® technology, introduced in 2016 as one of the first topical skincare formulas to combine a retinoid with an alpha hydroxy acid (AHA). The combination, used in the flagship AlphaRet Overnight Cream, was designed to
- New Peptide Serum Complements In-Office Aesthetic Treatmentshttps://modernaesthetics.com/news/new-peptide-serum-complements-in-office-aesthetic-treatments/2485257/ZO® Skin Health has introduced the Peptide Facial Refining Concentrate, an advanced at-home serum formulated to complement professional aesthetic procedures and enhance overall facial rejuvenation. The launch adds to the company’s physician-dispensed portfolio with
- Senolytic Skincare Platform Backed by First Peer-Reviewed Studyhttps://modernaesthetics.com/news/senolytic-skincare-platform-backed-by-first-peer-reviewed-study/2485088/Robles BioCeutics, a regenerative dermatology company focused on senolytic and stem cell–inspired approaches, has published its first peer-reviewed article in The Journal of Translational Medicine, validating the scientific basis of its proprietary skin regeneration platform. The
- FDA Clears Cutera truFlex® for Muscle Rehab, Recovery, and Post-Surgical Usehttps://modernaesthetics.com/news/fda-clears-cutera-truflex-for-muscle-rehab-recovery-and-post-surgical-use/2485023/Cutera, Inc. has announced that its truFlex® muscle stimulation system has received expanded US Food and Drug Administration (FDA) clearances for use in rehabilitation, recovery, and muscle wellness applications. Originally cleared for aesthetic body contouring, the system can now be used to stre